Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Some alternative treatments for hair loss might work, but more research is needed.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Finasteride reduces gambling symptoms in Parkinson's patients.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair restoration surgery effectively treats hair loss with natural-looking results, using techniques like stem cells and platelet-rich plasma.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.